Merck & Co. Inc. (MRK)

$ 119.30
   
  • Change Today:
    $-3.16
  • 52 Week High: $123.93
  • 52 Week Low: $73.47
  • Currency: US Dollars
  • Shares Issued: 2,527.64m
  • Volume: 10,327,287
  • Market Cap: $301,547m
  • RiskGrade: 92
  • Beta: 0.01

Merck Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Merck Financials

Latest F'cast
Div Yield 2.6%
Div Cover 2.2
Op Mrgn 31.1%
ROCE 43.9%
Latest F'cast
P/E 17.6
PEG 0.0
Pr/Revenue 4.7
Pr/Book 6.5
Latest F'cast
Revenue 6.7%
PBT 955.4%
EPS 4728.6%
DPS 5.4%

Merck Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 47,994.00 8,791.00 179.00¢ 45.7 n/a -53% 248.00¢ 3.0%
31-Dec-21 48,704.00 13,879.00 488.00¢ 15.7 0.1 +173% 264.00¢ 3.4%
31-Dec-22 59,283.00 16,444.00 573.00¢ 19.4 1.1 +17% 280.00¢ 2.5%
31-Dec-23 60,115.00 1,889.00 14.00¢ 778.7 n/a -98% 296.00¢ 2.7%
31-Dec-24 64,168.00 19,936.00 676.00¢ 14.7 0.0 +4,729% 312.00¢ 3.1%

Merck Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 66,720.45 17,851.51 512.27¢ 23.3 n/a -24% 322.31¢ 0.0%
31-Dec-27 70,241.95 29,232.43 971.82¢ 12.3 0.1 +90% 353.10¢ 0.0%
31-Dec-28 74,775.26 31,620.60 1,076.53¢ 11.1 1.0 +11% 364.85¢ 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Merck ShareCast News

Merck & Co to spin off cancer unit ahead of Keyt... 23-Feb-2026 ShareCast
Merck beats on fourth quarter revenue but disapp... 03-Feb-2026 ShareCast
Merck to buy Cidara Therapeutics in $9.2bn deal,... 14-Nov-2025 ShareCast

Merck Top Newspaper Links

Merck increases antibiotic offering with $9.5bn ... 09-Dec-2014 Telegraph
Reckitt Benckiser bows out of race for Merck's c... 01-May-2014 Telegraph
Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Merck Market Data

Currency US Dollars
Share Price $ 119.30
Change Today $ -3.16
% Change -2.58 %
52 Week High $123.93
52 Week Low $73.47
Volume 10,327,287
Shares Issued 2,527.64m
Market Cap $301,547m
Beta 0.01
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 10
Neutral 10
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 26-Feb-2026

Time Volume / Share Price
16:01 2,035,114 @ $119.30
15:59 100 @ $119.30
15:59 100 @ $119.30
15:59 100 @ $119.31
15:59 200 @ $119.32

Top of Page